We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

233 hedge funds and large institutions have $1.25B invested in iShares US Medical Devices ETF in 2018 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 89 increasing their positions, 59 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

569% more call options, than puts

Call options by funds: $9.47M | Put options by funds: $1.42M

51% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 59

16% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 44

2% more funds holding

Funds holding: 228233 (+5)

27% less capital invested

Capital invested by funds: $1.71B → $1.25B (-$466M)

27% less funds holding in top 10

Funds holding in top 10: 118 (-3)

41.7% less ownership

Funds ownership: 322.85%281.15% (-42%)

Holders
233
Holders Change
+5
Holders Change %
+2.19%
% of All Funds
5.19%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.18%
New
51
Increased
89
Reduced
59
Closed
44
Calls
$9.47M
Puts
$1.42M
Net Calls
+$8.06M
Net Calls Change
+$293M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
126
Claybrook Capital
Massachusetts
$591K +$614K +17,742 New
SG
127
StoneX Group
New York
$574K -$82.9K -2,394 -12%
TJHA
128
Thomas J. Herzfeld Advisors
Florida
$569K
SPC
129
Sigma Planning Corp
Michigan
$560K -$6.23K -180 -1%
CA
130
Cetera Advisors
Colorado
$560K +$26.4K +762 +5%
GTAM
131
Global Trust Asset Management
Florida
$555K -$92.9K -2,682 -14%
KA
132
Kovack Advisors
Florida
$543K +$44.3K +1,278 +9%
Susquehanna International Group
133
Susquehanna International Group
Pennsylvania
$534K -$13M -375,642 -96%
WS
134
Wedbush Securities
California
$530K +$551K +15,912 New
AIP
135
Almanack Investment Partners
Pennsylvania
$526K +$23.3K +672 +4%
KWM
136
Kingsview Wealth Management
Oregon
$515K +$77.3K +2,232 +17%
SMC
137
Smith, Moore & Co
Missouri
$482K +$22.6K +654 +5%
PWW
138
Pettyjohn Wood & White
Virginia
$468K +$16.6K +480 +4%
OGC
139
Oak Grove Capital
New Hampshire
$450K +$467K +13,500 New
OAJ
140
Ogorek Anthony Joseph
New York
$444K +$11.2K +324 +2%
FWSM
141
First Wilshire Securities Management
California
$440K
APA
142
American Portfolios Advisors
New York
$420K +$25.8K +744 +6%
GCM
143
Gibraltar Capital Management
Oklahoma
$413K +$429K +12,390 New
TC
144
TownSquare Capital
Utah
$403K +$388K +11,220 New
AI
145
Atria Investments
North Carolina
$401K -$3.58M -103,314 -90%
FUBT
146
First United Bank & Trust
Maryland
$398K +$45.3K +1,308 +12%
JMPWA
147
JP Morgan Private Wealth Advisors
California
$383K -$871K -25,164 -69%
WWM
148
Willingdon Wealth Management
North Carolina
$383K +$7.27K +210 +2%
SMFS
149
Squar Milner Financial Services
California
$374K
Creative Planning
150
Creative Planning
Kansas
$362K -$14.5K -420 -4%

IHI Hedge Fund Activity: Q4 2018 in Review

233 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q4 2018, worth a combined $1.25B — down 27% from $1.71B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new IHI positions and 44 closed out — a net gain of 7 holders — while 89 added to existing stakes and 59 trimmed.

The largest buyer was Discovery Capital Management, opening a new position worth an estimated $31.5M. The largest seller was Bank of Montreal, cutting an estimated $148M.

  • 233 institutional investors held iShares US Medical Devices ETF (IHI) as of Q4 2018, up from 228 in Q3 2018.
  • Funds reported $1.25B of iShares US Medical Devices ETF stock for Q4 2018, down 27% quarter-over-quarter.
  • 51 funds opened new iShares US Medical Devices ETF positions in Q4 2018 and 44 closed out, a net change of +7 holders.
  • The largest iShares US Medical Devices ETF buyer in Q4 2018 was Discovery Capital Management, an estimated $31.5M added.
  • The largest iShares US Medical Devices ETF seller in Q4 2018 was Bank of Montreal, an estimated $148M sold.

Based on aggregated 13F filings for Q4 2018.